Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis.
Affiliation
Birmingham Clinical Trials Unit, College of Medical and Dental Sciences, Public Health Building, University of Birmingham, Birmingham, B15 2TT, UKIssue Date
2017-09
Metadata
Show full item recordAbstract
Many randomised trials assessing interferon-α (IFN-α) as adjuvant therapy for high-risk malignant melanoma have been undertaken. To better assess the role of IFN-α, an individual patient data (IPD) meta-analysis of these trials was undertaken.Citation
Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis. 2017, 82:171-183 Eur J CancerJournal
European Journal of CancerDOI
10.1016/j.ejca.2017.06.006PubMed ID
28692949Type
ArticleLanguage
enISSN
1879-0852ae974a485f413a2113503eed53cd6c53
10.1016/j.ejca.2017.06.006
Scopus Count
Collections
Related articles
- Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis.
- Authors: Mocellin S, Pasquali S, Rossi CR, Nitti D
- Issue date: 2010 Apr 7
- Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991.
- Authors: Eggermont AM, Suciu S, Testori A, Kruit WH, Marsden J, Punt CJ, Santinami M, Salès F, Schadendorf D, Patel P, Dummer R, Robert C, Keilholz U, Yver A, Spatz A
- Issue date: 2012 Jan
- Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials.
- Authors: Wheatley K, Ives N, Hancock B, Gore M, Eggermont A, Suciu S
- Issue date: 2003 Aug
- Interferon alpha for the adjuvant treatment of cutaneous melanoma.
- Authors: Mocellin S, Lens MB, Pasquali S, Pilati P, Chiarion Sileni V
- Issue date: 2013 Jun 18
- Interferon alpha as adjuvant postsurgical treatment of melanoma: a meta-analysis.
- Authors: Pirard D, Heenen M, Melot C, Vereecken P
- Issue date: 2004